Modified adamts4 molecules and method of use thereof
CA 2492444 A1 · Owner: Corcoran, Christopher John · Inventors: Collins-Racie, Lisa A.; Lavallie, Edward R.; Mcdonagh, Thomas
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to modified ADAMTS4 proteins having improved stability comparing to the corresponding native unmodified proteins. The , modified ADAMTS4 proteins can be expressed and isolated in large quantities thus allowing further characterization of the proteins such as , crystallographic and enzyme kinetic studies. The purified stable proteins , would also facilitate the production of antiADAMTS antibodies and the development of inhibitors to ADAMTS enzymes.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 29, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 29, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 29, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.